Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Citigroup Reiterates Buy Rating on Figma, Inc. (FIG)
Citigroup reaffirmed its buy rating for Figma, Inc. with a target price of $36.
Wells Fargo Upgrades Carter's, Inc. to 'Hold' with $42 Target
Wells Fargo analyst Ike Boruchow upgrades Carter's, Inc. to 'hold' with a $42 price target.
Raymond James Upgrades Ventas, Inc. to a Buy Rating
Raymond James analyst David Rodgers boosts Ventas, Inc. with a buy rating and a $94 target.
Citizens Reiterates Buy Rating on ECPG
Citizens maintains its buy rating on ECPG with a $115 price target.
Raymond James Upgrades Welltower Inc. to 'Buy'
Raymond James has raised its rating on Welltower Inc. to 'buy' with a $226 price target.
JP Morgan Reiterates Sell Rating on Southern Copper
JP Morgan maintains a sell rating on Southern Copper with a $131.5 price target.
Raymond James Maintains Buy Rating on Permian Resources
Raymond James keeps its buy rating for Permian Resources with a $26 price target.
JP Morgan Reiterates Buy Rating on Valmont Industries
JP Morgan maintains its buy rating for Valmont Industries with a $600 price target.
Truist Securities Reiterates Buy Rating on Assurant, Inc.
Truist Securities maintains its Buy rating on Assurant, Inc. with a $310 price target.
Citizens Reiterates Buy Rating on SPHR with $200 Target
Citizens has reiterated its buy rating on SPHR, setting a $200 price target.
Truist Securities Reaffirms Buy Rating on CubeSmart
Truist Securities maintains its buy rating on CubeSmart with a $43 price target.
Truist Securities Reiterates Buy Rating on GRDN
Truist Securities maintains its Buy rating on GRDN with a price target of $47.
Truist Securities Reiterates Buy Rating on LINE
Truist Securities maintains its 'buy' rating for LINE, setting a $46 price target.
Leerink Partners Reiterates Buy Rating on Ionis Pharmaceuticals
Leerink Partners reaffirms its buy rating on Ionis Pharmaceuticals with a $122 price target.
Leerink Partners Reiterates Buy Rating on UnitedHealth Group
Leerink Partners maintains a Buy rating on UnitedHealth Group with a $462 target.
Stephens Reiterates Buy Rating on SailPoint, Inc. (SAIL)
Stephens maintains its buy rating on SailPoint, setting a $20 price target.
Canaccord Genuity Reiterates Buy Rating on CENTA
Canaccord Genuity maintains its buy stance on CENTA, setting a $53 price target.
Canaccord Genuity Reiterates Buy Rating on Spectrum Brands
Canaccord Genuity maintains its buy rating on Spectrum Brands with a $99 price target.
Oppenheimer Reiterates Buy Rating on The Middleby Corporation
Oppenheimer maintains its buy rating for The Middleby Corporation with a $205 target price.
Oppenheimer Reiterates Buy Rating on BrightView Holdings, Inc.
Oppenheimer maintains a positive outlook on BrightView, setting a $17 price target.
Oppenheimer Reiterates Buy Rating on Corbus Pharmaceuticals
Oppenheimer maintains its bullish stance on Corbus Pharmaceuticals with a $52 price target.
Freedom Broker Reiterates Buy Rating on Onto Innovation Inc.
Onto Innovation Inc. received a reiterated buy rating from Freedom Broker with a $370 target.
Benchmark Reiterates Buy Rating on CNK
Benchmark maintains its buy rating on CNK, setting a $37 price target.
Benchmark Reiterates Buy Rating on Coinbase Global, Inc.
Benchmark maintains a buy rating for Coinbase with a $270 price target.